IRIS Accounts Production v24.3.0.553 09961752 Board of Directors Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099617522023-01-31099617522024-01-31099617522023-02-012024-01-31099617522022-01-31099617522022-02-012023-01-31099617522023-01-3109961752ns15:EnglandWales2023-02-012024-01-3109961752ns14:PoundSterling2023-02-012024-01-3109961752ns10:Director12023-02-012024-01-3109961752ns10:Director22023-02-012024-01-3109961752ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3109961752ns10:SmallEntities2023-02-012024-01-3109961752ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3109961752ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3109961752ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3109961752ns10:FullAccounts2023-02-012024-01-3109961752ns10:RegisteredOffice2023-02-012024-01-3109961752ns5:CurrentFinancialInstruments2024-01-3109961752ns5:CurrentFinancialInstruments2023-01-3109961752ns5:ShareCapital2024-01-3109961752ns5:ShareCapital2023-01-3109961752ns5:RetainedEarningsAccumulatedLosses2024-01-3109961752ns5:RetainedEarningsAccumulatedLosses2023-01-3109961752ns5:PlantMachinery2023-02-012024-01-3109961752ns5:PlantMachinery2023-01-3109961752ns5:PlantMachinery2024-01-3109961752ns5:PlantMachinery2023-01-3109961752ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3109961752ns5:WithinOneYearns5:CurrentFinancialInstruments2023-01-31
REGISTERED NUMBER: 09961752 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Petheram Medical Limited

Petheram Medical Limited (Registered number: 09961752)






Contents of the Financial Statements
for the Year Ended 31 January 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Petheram Medical Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: T G Petheram
Dr K R Petheram





REGISTERED OFFICE: Widehaugh House
Corbridge Road
Hexham
Northumberland
NE46 1UW





REGISTERED NUMBER: 09961752 (England and Wales)





ACCOUNTANTS: Yorkshire Medical Accountants LLP
Suite 12
East Wing, Jason House
Kerry Hill, Horsforth
Leeds
West Yorkshire
LS18 4JR

Petheram Medical Limited (Registered number: 09961752)

Balance Sheet
31 January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 16,411 21,301

CURRENT ASSETS
Debtors 5 488 26,914
Investments 6 236,162 180,712
Cash at bank and in hand 32,763 16,030
269,413 223,656
CREDITORS
Amounts falling due within one year 7 15,364 19,690
NET CURRENT ASSETS 254,049 203,966
TOTAL ASSETS LESS CURRENT
LIABILITIES

270,460

225,267

PROVISIONS FOR LIABILITIES 3,118 4,047
NET ASSETS 267,342 221,220

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings 267,341 221,219
SHAREHOLDERS' FUNDS 267,342 221,220

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Petheram Medical Limited (Registered number: 09961752)

Balance Sheet - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 October 2024 and were signed on its behalf by:




T G Petheram - Director



Dr K R Petheram - Director


Petheram Medical Limited (Registered number: 09961752)

Notes to the Financial Statements
for the Year Ended 31 January 2024

1. STATUTORY INFORMATION

Petheram Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 2 ) .

Petheram Medical Limited (Registered number: 09961752)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2023 33,052
Additions 1,348
At 31 January 2024 34,400
DEPRECIATION
At 1 February 2023 11,751
Charge for year 6,238
At 31 January 2024 17,989
NET BOOK VALUE
At 31 January 2024 16,411
At 31 January 2023 21,301

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors - 26,434
Other debtors 488 480
488 26,914

6. CURRENT ASSET INVESTMENTS
31.1.24 31.1.23
£    £   
Unlisted investments 236,162 180,712

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade creditors 27 27
Taxation and social security 13,560 17,972
Other creditors 1,777 1,691
15,364 19,690

8. RELATED PARTY DISCLOSURES

During the year, total dividends of £2,000 (2023 - £4,000) were paid to the directors .

Included in other creditors at the year end is an amount owed to the directors of £415 (2023 - £415).